39th week of 2019 patent applcation highlights part 9 |
Patent application number | Title | Published |
20190290570 | COMPOSITIONS FOR REMOVING COSMETIC FILMS | 2019-09-26 |
20190290571 | Cosmetic Formulation | 2019-09-26 |
20190290572 | COSMETIC RAW MATERIAL USING CORE-CORONA TYPE MICROPARTICLES AND OIL-IN-WATER EMULSIFIED COSMETIC | 2019-09-26 |
20190290573 | HAIR CARE COMPOSITIONS COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS | 2019-09-26 |
20190290574 | TOPICAL SKIN CARE COMPOSITIONS COMPRISING MYRSINE AFRICANA EXTRACTS | 2019-09-26 |
20190290575 | TOPICAL COMPOSITIONS AND METHODS | 2019-09-26 |
20190290576 | ANTI-MALARIAL PHARMACEUTICAL COMPOSITION | 2019-09-26 |
20190290577 | TOPICAL ANTIVIRAL COMPOSITIONS, DELIVERY SYSTEMS, AND METHODS OF USING THE SAME | 2019-09-26 |
20190290578 | STABLE ORAL SOLUTIONS FOR COMBINED API | 2019-09-26 |
20190290579 | ORALLY DISINTEGRATING TABLET HAVING INNER CORE | 2019-09-26 |
20190290580 | EMULSION | 2019-09-26 |
20190290581 | NOVEL METHOD TO SLOW VENTRICULAR RATE | 2019-09-26 |
20190290582 | VAGINAL HYDROGEL FOR DELIVERY OF THERAPEUTICS | 2019-09-26 |
20190290583 | METHODS OF TREATING ARTHRITIS | 2019-09-26 |
20190290584 | TARGETED DELIVERY OF DRUGS TO THE MYOMETRIUM | 2019-09-26 |
20190290585 | EV-MEDIATED DELIVERY OF BINDING PROTEIN-SMALL MOLECULE CONJUGATES | 2019-09-26 |
20190290586 | METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF CRYSTALLINE MICROPARTICLE SURFACES FOR ACTIVE AGENTS | 2019-09-26 |
20190290587 | PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA | 2019-09-26 |
20190290588 | STABLE BILAYER TABLET COMPOSITIONS | 2019-09-26 |
20190290589 | COMPOSITIONS AND RESULTING HARD CAPSULES COMPRISING HYDROPHILIC COLORING FOODSTUFF CONCENTRATES | 2019-09-26 |
20190290590 | INSTANT RELEASE CAPSULE BASED ON HOT MELT EXTRUDED POLYVINYL ALCOHOL | 2019-09-26 |
20190290591 | TASTE-MASKED PHARMACEUTICAL COMPOSITIONS WITH GASTROSOLUBLE PORE-FORMERS | 2019-09-26 |
20190290592 | Nanoparticles for Brain Targeted Drug Delivery | 2019-09-26 |
20190290593 | TARGETING THE INNATE IMMUNE SYSTEM TO INDUCE LONG-TERM TOLERANCE AND TO RESOLVE MACROPHAGE ACCUMULATION IN ATHEROSCLEROSIS | 2019-09-26 |
20190290594 | MANGIFERIN ENCAPSULATED GOLD NANOPARTICLES, FABRICATION METHODS AND CANCER THERAPEUTIC METHODS | 2019-09-26 |
20190290595 | DEVICE AND METHOD OF TREATING CONDITIONS ASSOCIATED WITH NEUROINFLAMMATION | 2019-09-26 |
20190290596 | PRODUCTION METHOD OF PREGABALIN-CONTAINING COMPOSITION AND PREGABALIN-CONTAINING COMPOSITION | 2019-09-26 |
20190290597 | DERMAL AND TRANSDERMAL ADMINISTRATION OF TREPROSTINIL AND SALTS THEREOF | 2019-09-26 |
20190290598 | ISOXYLITONES MEDIATED NEUROGENESIS | 2019-09-26 |
20190290599 | LIVER PROTECTANT COMPOSITIONS AND THERAPEUTIC APPLICATIONS | 2019-09-26 |
20190290600 | Method for Treating Depression | 2019-09-26 |
20190290601 | BUPROPION AND DEXTROMETHORPHAN FOR TREATING NICOTINE ADDICTION | 2019-09-26 |
20190290602 | EPINEPHRINE COMPOSITIONS AND CONTAINERS | 2019-09-26 |
20190290603 | TITRATION OF TAPENTADOL | 2019-09-26 |
20190290604 | Uses of Curcumin Derivative | 2019-09-26 |
20190290605 | COMPOSITIONS AND METHODS FOR TREATING ECZEMA | 2019-09-26 |
20190290606 | ANTISEPTIC, ANTISEBORRHEIC AND EXFOLIATING COMPOSITION TO REMOVE OR PREVENT ACNE | 2019-09-26 |
20190290607 | ADMINISTRATION OF ORAL METHYLDOPA | 2019-09-26 |
20190290608 | COMPOSITIONS COMPRISING MAGNOLIA, PHELLODENDRON, THEANINE AND/OR WHEY PROTEIN | 2019-09-26 |
20190290609 | PHARMACEUTICAL COMPOSITION COMPRISING PALMITOYLETHANOLAMIDE AND L-ACETYLCARNITINE | 2019-09-26 |
20190290610 | TRIHEPTANOIN FOR THE TREATMENT OF GLUCOSE TRANSPORT 1 DEFICIENCY | 2019-09-26 |
20190290611 | CIS-GNETIN H AND TRANS-GNETIN H AS THERAPEUTIC AGENTS | 2019-09-26 |
20190290612 | METHODS FOR TREATING PULMONARY FIBROSIS | 2019-09-26 |
20190290613 | USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING | 2019-09-26 |
20190290614 | Methods for Reducing Recurrence of Tumors | 2019-09-26 |
20190290615 | NON-HORMONAL COMPOSITIONS AND METHODS FOR MALE CONTRACEPTION | 2019-09-26 |
20190290616 | METHODS OF TREATING TTR AMYLOIDOSIS USING AG10 | 2019-09-26 |
20190290617 | NOVEL USE OF SESQUITERPENE DERIVATIVE | 2019-09-26 |
20190290618 | Method for Treating Obesity | 2019-09-26 |
20190290619 | USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS | 2019-09-26 |
20190290620 | APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES | 2019-09-26 |
20190290621 | COMPOSITIONS AND METHODS FOR TREATING HIV-1 LATENCY | 2019-09-26 |
20190290624 | SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID, COMPOSITIONS, AND USES THEREOF | 2019-09-26 |
20190290625 | METHOD OF TREATMENT WITH TRADIPITANT | 2019-09-26 |
20190290626 | METHOD OF TREATMENT WITH TRADIPITANT | 2019-09-26 |
20190290627 | PIM KINASE INHIBITOR COMBINATIONS | 2019-09-26 |
20190290628 | N3,N6-BIS(2-(5-METHOXY-1H-INDOLE-3-YL)ETHYL)-2,6-DIMETHYL-4-(2-NITROPHENYL- )PYRIDINE-3,5-DICARBOXAMIDE AND USE THEREOF IN THE FIELD OF NEUROTOXICITY | 2019-09-26 |
20190290629 | NIRAPARIB SUSTAINED AND CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2019-09-26 |
20190290630 | Combination Therapy Including an MDM2 Inhibitor and One or More Additional Pharmaceutically Active Agents for the Treatment of Cancers | 2019-09-26 |
20190290631 | PHARMACEUTICAL COMPOSITION COMPRISING RAPAMYCIN OR DERIVATIVE THEREOF | 2019-09-26 |
20190290632 | Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy | 2019-09-26 |
20190290634 | COMPOSITIONS AND METHODS FOR INHIBITING DIHYDROOROTATE DEHYDROGENASE | 2019-09-26 |
20190290635 | METHODS OF TREATING BRAIN CANCER USING AGENTS THAT ALTER ACTIVITY OF A METABOLIC PATHWAY | 2019-09-26 |
20190290636 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | 2019-09-26 |
20190290637 | NEW PHENYLPYRAZOLYLACETAMIDE COMPOUNDS AND DERIVATIVES AS CDK8/CDK19 INHIBITORS | 2019-09-26 |
20190290638 | SUBCUTANEOUS DELIVERY OF POLY(OXAZOLINE) POLYMER CONJUGATES | 2019-09-26 |
20190290639 | COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS | 2019-09-26 |
20190290640 | Methods Of Providing Weight Loss Therapy In Patients With Major Depression | 2019-09-26 |
20190290641 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR SKIN AND/OR HAIR REPAIR | 2019-09-26 |
20190290642 | Therapy for Mitochondrial Fatty Acid Beta-Oxidation and Transport Disorders | 2019-09-26 |
20190290643 | COMPOSITIONS AND METHODS OF USING NINTEDANIB FOR IMPROVING GLAUCOMA SURGERY SUCCESS | 2019-09-26 |
20190290644 | Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia Using a BTK Inhibitor | 2019-09-26 |
20190290645 | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy | 2019-09-26 |
20190290646 | HDAC INHIBITORS FOR USE WITH NK CELL BASED THERAPIES | 2019-09-26 |
20190290647 | ALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | 2019-09-26 |
20190290648 | CYCLOALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | 2019-09-26 |
20190290649 | SHP2 INHIBITORS AND USES THEREOF | 2019-09-26 |
20190290650 | FORMULATIONS/COMPOSITIONS COMPRISING A BTK INHIBITOR | 2019-09-26 |
20190290651 | COMBINATIONS FOR THE TREATMENT OF NEOPLASMS USING QUIESCENT CELL TARGETING AND INHIBITORS OF MITOSIS | 2019-09-26 |
20190290652 | METHOD FOR TREATMENT OF SOLID MALIGNANCIES INCLUDING ADVANCED OR METASTATIC SOLID MALIGNANCIES | 2019-09-26 |
20190290653 | TREATMENT OF SKIN LESIONS | 2019-09-26 |
20190290654 | DNA-PK INHIBITORS | 2019-09-26 |
20190290655 | NOVEL METHODS | 2019-09-26 |
20190290656 | PT(IV) PRODRUGS | 2019-09-26 |
20190290657 | METHOD FOR TREATING CONDITIONS ASSOCIATED WITH HYPERPROLIFERATING CELLS COMPRISING COMBINED ADMINISTRATION OF A CANNABINOID RECEPTOR AGONIST AND RADIATION THERAPY | 2019-09-26 |
20190290658 | THERAPEUTIC COMPOUNDS AND COMPOSITIONS FOR TREATING SOCIAL DISORDERS AND SUBSTANCE USE DISORDERS | 2019-09-26 |
20190290659 | INHIBITORS OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE FOR TREATING CARDIOVASCULAR AND PULMONARY CONDITIONS | 2019-09-26 |
20190290660 | PHARMACEUTICAL COMPOSITION AND USE | 2019-09-26 |
20190290661 | USE OF CICLESONIDE FOR THE TREATMENT OF RESPIRATORY DISEASES | 2019-09-26 |
20190290662 | COMPOSITIONS AND METHODS FOR TREATING ACNE VULGARIS | 2019-09-26 |
20190290663 | One-stop Surgical Method of Coronary Intervention Therapy Combined with Endovascular Aortic Repair | 2019-09-26 |
20190290664 | NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2019-09-26 |
20190290665 | NERIDRONIC ACID AND OTHER BISPHOSPHONATES FOR TREATING COMPLEX REGIONAL PAIN SYNDROME AND OTHER DISEASES | 2019-09-26 |
20190290666 | COMPOSITION COMPRISING KETONE BODY AND NICOTINAMIDE ADENINE DINUCLEOTIDE MODULATOR AND METHYL DONOR | 2019-09-26 |
20190290667 | MIXTURES OF HMOs | 2019-09-26 |
20190290668 | COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF URT INFECTIONS IN INFANTS OR YOUNG CHILDREN AT RISK | 2019-09-26 |
20190290669 | N-PALMITOYL-D-GLUCOSAMINE IN A MICRONIZED FORM | 2019-09-26 |
20190290670 | METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS | 2019-09-26 |
20190290671 | HYPOLIPIDEMIC EFFECTS OF COMPOSITIONS COMPRISING BETA-GLUCOGALLIN | 2019-09-26 |
20190290672 | USE OF LYSIN TO RESTORE/AUGMENT ANTIBACTERIAL ACTIVITY IN THE PRESENCE OF PULMONARY SURFACTANT OF ANTIBIOTICS INHIBITED THEREBY | 2019-09-26 |